The study by Matsushita et al. (2021) showed that in prostate-specific Pten-knockout mice, SCFA supplementation promoted tumor growth by increasing IGF1 levels and activated local MAPK and PI3K signaling in the tumor-transformed prostate. This evidence concerns the gene PTEN and neoplasm.